Vetco

Vetco is a Taiwan-based veterinary biopharmaceutical and animal health company focused on oncology products and pathology diagnostic services for companion animals. The company states that it was founded in 2012 and developed Antican, a novel anti-cancer injectable formulated for companion animal use and launched in Taiwan in October 2017. In addition to drug development, Vetco operates animal pathology diagnostic and pharmacological pathology laboratory services. The business appears centered on veterinary oncology and related diagnostic infrastructure rather than a broad human biotech pipeline. Public disclosures and company materials indicate an active operating business in Taiwan, although available evidence suggests a relatively narrow commercial product portfolio.